Enerpac Tool
EPAC
Precision Drilling
PDS
Halozyme Therapeutics
HALO
4
Workday
WDAY
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
DMAAU Drugs Made in America Acquisition Corp.
- 10.170
- +0.042+0.42%
Close Mar 25 16:00 ET
207.47MMarket Cap0.00P/E (TTM)
10.170High10.110Low451Volume10.110Open10.128Pre Close4.57KTurnover0.00%Turnover Ratio0.00P/E (Static)20.40MShares10.82052wk High-1271.25P/B203.40MFloat Cap10.00052wk Low--Dividend TTM20.00MShs Float10.820Historical High--Div YieldTTM0.59%Amplitude10.000Historical Low10.139Avg Price1Lot Size
About Drugs Made in America Acquisition Corp. Company
Drugs Made In America Acquisition Corp. is a blank check company. It is an exempt company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in Fort Lauderdale, FL.
Company Profile
SymbolDMAAU
Company NameDrugs Made in America Acquisition Corp.
Listing DateFeb 25, 2025
Issue Price10.00
CEOMs. Lynn Stockwell
MarketNASDAQ
Employees2
Fiscal Year Ends12-31
Address1 East Broward Boulevard,Suite 700
CityFort Lauderdale
ProvinceFlorida
CountryUnited States of America
Zip Code33301
Phone1-954-870-3099
Company Executives
- Name
- Position
- Salary
- Lynn Stockwell
- Chief Executive Officer and Executive Chairman of the Board
- --
- Glenn C. Worman
- Chief Financial Officer
- --
- Myron W. Shulgan
- Independent Director
- --
- Dr. G. Sridhar Prasad
- Independent Director
- --
- Dr. Catherine Do
- Independent Director
- --
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025